New treatment helps achieve a healthier BMI in people with weight dysregulation after brain tumors

Дата публикации: 09-07-2026 16:00:09

A new therapy helps achieve a healthier BMI in people whose weight has become dysregulated following treatment for a brain tumor, a clinical trial has found. The results of the trial have been published in the New England Journal of Medicine. The new drug, setmelanotide, offers hope for improved health and quality of life for children and adults with hormonal and metabolic dysfunction caused by a brain tumor.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Weight‑loss jabs may create a new kind of yo‑yo dieting	0	7	10-07-2026
2	Найден способ вылечить редкую форму ожирения	7	8	09-07-2026
3	7 things to know about Medicare's new GLP-1 coverage	0	7	02-07-2026
4	Weight-loss jab users more likely to report changes in taste and smell, study finds	0	7	29-06-2026
5	Bofanglutide linked to meaningful reductions in HbA1c in adults with T2DM	5	7	02-07-2026
6	GLP-1 use hits record high as Medicare opens access to weight-loss drugs	0	7	09-07-2026
7	Societies combine to issue recommendations on use of incretin drugs in obesity therapy	0	7	09-07-2026
8	Ученые выяснили, как остановить развитие меланомы	0	0	04-01-2019
9	حقنة جديدة تبعث الأمل.. علاج واعد يقضي على أورام السرطان	7	8	01-06-2026
10	Wegovy pills 'are just as good as fat jabs when it comes to weight loss - but injections are better for your heart'	0	5	09-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 5. Информативность: 7. Источник: medicalxpress.com.